The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment
Open accessAbstract
Primary aldosteronism is characterized by aldosterone secretion that is independent of renin and angiotensin II and sodium status. The deleterious effects of primary aldosteronism are mediated by excessive activation of the mineralocorticoid receptor that results in the well-known consequences of volume expansion, hypertension, hypokalemia, and metabolic alkalosis, but it also increases the risk for cardiovascular and kidney disease, as well as death. For decades, the approaches to defining, diagnosing, and treating primary aldosteronism have been relatively constant and generally focused on detecting and treating the more severe presentations of the disease. However, emerging evidence suggests that the prevalence of primary aldosteronism is much greater than previously recognized, and that milder and nonclassical forms of renin-independent aldosterone secretion that impart heightened cardiovascular risk may be common. Public health efforts to prevent aldosterone-mediated end-organ disease will require improved capabilities to diagnose all forms of primary aldosteronism while optimizing the treatment approaches such that the excess risk for cardiovascular and kidney disease is adequately mitigated. In this review, we present a physiologic approach to considering the diagnosis, pathogenesis, and treatment of primary aldosteronism. We review evidence suggesting that primary aldosteronism manifests across a wide spectrum of severity, ranging from mild to overt, that correlates with cardiovascular risk. Furthermore, we review emerging evidence from genetic studies that begin to provide a theoretical explanation for the pathogenesis of primary aldosteronism and a link to its phenotypic severity spectrum and prevalence. Finally, we review human studies that provide insights into the optimal approach toward the treatment of primary aldosteronism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–237 of 237
Kline, G. A., Pasieka, J. L., Harvey, A. M., So, B., & Dias, V. C. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2871-3 · Cited by 50
Cornu, E., Steichen, O., Nogueira‐Silva, L., Küpers, E. M., Pagny, J.-Y., Grataloup, C., Baron, S., Zinzindohoué, F., Plouin, P., & Amar, L. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07214 · Cited by 50
Cheville, R., Luetscher, J. A., Hancock, E. W., et al. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105437 · Cited by 49
Primary aldosteronism as a cause of secondary osteoporosis
Salcuni, A. S., Carnevale, V., Battista, C., Palmieri, S., Eller-Vainicher, C., Guarnieri, V., Pugliese, F., Guglielmi, G., Desina, G., Minisola, S., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0417 · Cited by 49
Confirmatory Tests in the Diagnosis of Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Mengozzi, G., Tizzani, D., Iannaccone, A., & Veglio, F. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246186 · Cited by 48
Self-citationDisordered CYP11B2 Expression in Primary Aldosteronism
Gómez-Sánchez, C. E., Kuppusamy, M., Reincke, M., & Williams, T. A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122238 · Cited by 48
Nagase, M. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0298-8 · Cited by 46
Arnesen, T., Glomnes, N., Strømsøy, S., Knappskog, S., Heie, A., Akslen, L. A., Grytaas, M. A., Varhaug, J. E., Gimm, O., & Brauckhoff, M. (2013) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-013-1093-2 · Cited by 45
Diaz‐Otero, J. M., Fisher, C. L., Downs, K., Moss, M. E., Jaffe, I. Z., Jackson, W. F., & Dorrance, A. M. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09598 · Cited by 45
Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II
Takeda, Y., Demura, M., Wang, F., Karashima, S., Yoneda, T., Kometani, M., Hashimoto, A., Aono, D., Horike, S., Meguro‐Horike, M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008281 · Cited by 45
(1955) · JAMA · doi:10.1001/jama.1955.02960160038009 · Cited by 43
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism
Prada, E. T. A., Burrello, J., Reincke, M., & Williams, T. A. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10111 · Cited by 39
TAKAKUWA, H., Shimizu, K., Izumiya, Y., Kato, T., Nakaya, I., Yokoyama, H., KOBAYASHI, K. P., & Ise, T. (2002) · Hypertension Research · doi:10.1291/hypres.25.737 · Cited by 37
Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism
Auchus, R. J., Chandler, D. W., Singeetham, S., Chokshi, N., Nwariaku, F. E., Dolmatch, B. L., Holt, S. A., Wians, F. H., Josephs, S. C., Trimmer, C. K., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2631 · Cited by 35
Rossi, G. P., & Funder, J. W. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08820 · Cited by 35
Local Control of Aldosterone Production and Primary Aldosteronism
Lalli, E., Barhanin, J., Zennaro, M., & Warth, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.01.003 · Cited by 34
Effects of Treating Primary Aldosteronism on Renal Function
Kramers, B. J., Kramers, C., Lenders, J. W. M., & Deinum, J. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12914 · Cited by 33
Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation
Barrett, K. V., McCurley, A., & Jaffe, I. Z. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12125 · Cited by 32
Integrated Concentration of Plasma Aldosterone in Normal Subjects: Correlation with Cortisol*
Kowarski, A. A., de Lacerda, L., & Migeon, C. J. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-2-205 · Cited by 32
The steroidogenic response to angiotensin II in the Australian lungfish, Neoceratodus forsteri
Joss, J. M. P., Arnold-Reed, D. E., & BALMENT, R. J. (1994) · Journal of Comparative Physiology B · doi:10.1007/bf00302553 · Cited by 31
Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism
Ip, J. C. Y., Pang, T., Pon, C. K., Zhao, J., Sywak, M. S., Gill, A. J., Soon, P., & Sidhu, S. B. (2013) · ANZ Journal of Surgery · doi:10.1111/ans.12470 · Cited by 29
Carvajal, C. A., Campino, C., Martínez‐Aguayo, A., Tichauer, J. E., Bancalari, R. E., Valdivia, C. P., Trejo, P., Marlene Aglony, I., Baudrand, R. F., Lagos, C. F., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180513 · Cited by 28
Self-citationGenetic and Histopathologic Intertumor Heterogeneity in Primary Aldosteronism
Omata, K., Yamazaki, Y., Nakamura, Y., Anand, S. K., Barletta, J. A., Sasano, H., Rainey, W. E., Tomlins, S. A., & Vaidya, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-4007 · Cited by 26
Self-citationThe Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives ∗
Maiolino, G., Calò, L. A., & Rossi, G. P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.041 · Cited by 25
Primary Aldosteronism: The Next Five Years
Funder, J. W. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-119802 · Cited by 25
Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome
Valaiyapathi, B., & Calhoun, D. A. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0819-5 · Cited by 23
An Individualized Approach to The Evaluation and Management of Primary Aldosteronism
Vaidya, A., Malchoff, C. D., & Auchus, R. J. (2017) · Endocrine Practice · doi:10.4158/ep161717.ra · Cited by 21
Self-citationRye, P., Chin, A., Pasieka, J. L., So, B., Harvey, A. M., & Kline, G. A. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12523 · Cited by 20
P., P. J. (1975) · Journal of The Royal Naval Medical Service · doi:10.1136/jrnms-61-119c · Cited by 18
Effect of mineralocorticoid receptor blockade on hippocampal‐dependent memory in adults with obesity
Rotenstein, L. S., Sheridan, M. A., Garg, R., & Adler, G. K. (2015) · Obesity · doi:10.1002/oby.21104 · Cited by 17
Self-citationSubclinical Primary Aldosteronism
Adlin, E. V. (2017) · Annals of Internal Medicine · doi:10.7326/m17-2237 · Cited by 15
Medical Versus Surgical Treatment of Primary Aldosteronism
Calhoun, D. A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10759 · Cited by 15
Kobuke, K., Oki, K., Gómez-Sánchez, C. E., Ohno, H., Itcho, K., Yoshii, Y., Yoneda, M., & Hattori, N. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01996 · Cited by 10
Adrenal Venous Sampling for Differentiating Unilateral From Bilateral Primary Aldosteronism
Stowasser, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.04930 · Cited by 9
Aldosterone Hypothesis for Cognitive Impairment in Diabetes Mellitus
Saha, S., Bornstein, S. R., Graessler, J., Chakrabarti, S., & Kopprasch, S. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-115226 · Cited by 9
Adrenal vein sampling for subtyping in primary aldosteronism
Reincke, M. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30113-9 · Cited by 5
Satoh, F., Morimoto, R., Ono, Y., Iwakura, Y., Omata, K., Kudo, M., Tkase, K., Seiji, K., Gómez-Sánchez, C. E., Rainey, W. E., et al. (2015) · Journal of Hypertension · doi:10.1097/01.hjh.0000467656.46285.fb · Cited by 1
Cited by
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study
Brown, J. M., Siddiqui, M., Calhoun, D. A., Carey, R. M., Hopkins, P. N., Williams, G. H., & Vaidya, A. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0065 · Cited by 649
Self-citationPrimary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Adler, G. K., Stowasser, M., Correa, R. R., Khan, N., Kline, G., McGowan, M. J., Mulatero, P., Murad, M. H., Touyz, R. M., Vaidya, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf284 · Cited by 355
Self-citationMulatero, P., Monticone, S., Deinum, J., Amar, L., Prejbisz, A., Zennaro, M.-C., Beuschlein, F., Rossi, G. P., Nishikawa, T., Morganti, A., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002510 · Cited by 317
Self-citationPrimary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment
Hundemer, G. L. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1185-x · Cited by 27
Metadata
- Authors
- Vaidya, A., Mulatero, P., Baudrand, R., & Adler, G. K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2018-08-15
- Volume
- 39
- Issue
- 6
- Pages
- 1057-1088
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2887931962
- Cited by
- 299
- References
- 237
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.